<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Comments on: Caliway Unveils Latest OI25 Animal Study Data for CBL-514 in Combination with GLP-1R-Based Weight-Loss Therapies at ADA 2026, Demonstrating Dual Potential to Attenuate Post-Discontinuation Weight Regain and Improve Metabolic Health	</title>
	<atom:link href="https://9krapalm.com/caliway-unveils-latest-oi25-animal-study-data-for-cbl-514-in-combination-with-glp-1r-based-weight-loss-therapies-at-ada-2026-demonstrating-dual-potential-to-attenuate-post-discontinuation-weight-rega/feed/" rel="self" type="application/rss+xml" />
	<link>https://9krapalm.com/caliway-unveils-latest-oi25-animal-study-data-for-cbl-514-in-combination-with-glp-1r-based-weight-loss-therapies-at-ada-2026-demonstrating-dual-potential-to-attenuate-post-discontinuation-weight-rega/</link>
	<description>เสิร์ฟข่าวไอที อัปเดตเทคโนโลยีสไตล์ @krapalm</description>
	<lastBuildDate>Thu, 11 Jun 2026 05:11:59 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>
</channel>
</rss>
